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Duchenne’s Muscular dystrophy (DMD) is a congenital disease of the muscle
characterized by muscle atrophy, weakness, and a lower quality of life. Often diagnosed in
children, it affects about 1 in every 5,500-7,700 males. A patient diagnosed with DMD is often
told to avoid physical activities outside the required amount needed to go on with their day in
order to preserve the muscle fibers and integrity. Inactivity in a healthy person leads to decreased
muscle mass and increased weakening of the muscle, so we questioned if the effects may be
exacerbated in a person diagnosed with DMD having already weakened muscle. In other words,
‘does inactivity make disease progression worse?’ In this project, we explored the effects of
inactivity on a zebrafish model of DMD. We used N-Benzyl-p-toluene sulfonamide (BTS), a
myosin heavy chain inhibitor, to induce total inactivity for 72-hours consecutively at disease
onset (2 days post fertilization), followed by a 72-hour recovery period out of BTS where normal
activity is resumed. This setup mimics activity levels that a DMD patient may experience;
periods of inactivity advised by doctors to preserve muscle fibers followed by use of the muscle
for an activity such as physical therapy. We then analyzed the effects on muscle structure (via
birefringence) and function (via swimming distance and velocity), as well as survival. Based on

previous studies done on inactivity and muscle health, we hypothesized that extended inactivity
would have a deleterious effect on the structure and function of the muscle fibers as well as
survival. We found that muscle structure and function was not significantly different than control
disease progression after extended inactivity. Survival was also not significantly different from
the control. The results of this data show us that while extended inactivity did not worsen disease
progression as compared to the control, inactivity did not improve muscle structure and function
or survival. This data is an important step in understanding the effects of inactivity on disease
progression in DMD in hopes to provide better management and therapy towards DMD.
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CHAPTER 1:
INTRODUCTION

1.1 Skeletal Muscle Structure and Function
Skeletal muscle is one of the 3 main types of muscle found within the body, the other two
being smooth and cardiac muscle. Skeletal muscle’s main function is to control the motor
movements the body uses for any activity such as walking, breathing, running, etc., and its
structure is uniform across the entire body. However, skeletal muscle has roles in many other
functions in the human body, including temperature regulation and endocrine function 1.
Overall, Skeletal muscle is an extremely important organ and proper skeletal muscle health is
imperative for whole-body health and wellness.
1.1.1 Skeletal Muscle Structure
Aside from being one of the most dynamic and plastic tissues in the human body, skeletal
muscle has a uniform structure that is preserved across each area of the body it occurs in 2.
Skeletal muscle can be visualized as a series of cylinders wrapped inside another series of
cylinders, continuing into the molecular level (Figure 1a). For example, the bicep of the arm,
the muscle that causes adduction of the forearm, is constructed of multinucleate muscle cells,
called muscle fibers, bundled together in a muscle fascicle. These muscle fibers are made up
of myofibrils, which are strings of the structures that produces muscle contraction: the
sarcomere (Figure 1). The sarcomere is where skeletal muscle myosin interacts with F-Actin
filaments to shorten the muscle; many other proteins are involved to make this contraction
work, but my thesis will only focus on actin and myosin. ATP is hydrolyzed so that the
myosin heads can slide along the actin filaments, shortening the sarcomere 2. When this
1

process is occurs across the myofibril, a contraction is produced. Relaxation of the
sarcomeres happens when Actin is no longer actively moved by myosin. This muscle
relaxation allows it to extend, such as when you put the weight down and relax your arm.

Figure 1. Skeletal muscle structure, from Frontera and Ochala, 2014. The muscle consists of a
muscle fiber (a), which contains the myofibril (b). Inside each myofibril contains the basic
contractile unit of skeletal muscle: the sarcomere (c). The sarcomere contains the proteins actin
and myosin, which interact to perform the contraction needed to move the body (d).

1.1.2 Skeletal Muscle Function
Skeletal muscle’s primary function in an organism is locomotory. Any voluntary
movement requires the use of skeletal muscle. Maintaining an upward posture on two legs is
2

only able to be achieved via our skeletal muscle. This is done through the contraction of the
muscle fibers in unison in the specific muscle being used (see section 1.1). However,
movement is not the only function of the skeletal muscle; it also has metabolic functions and
is vital to thermoregulation.
When an individual partakes in intense exercise, the body will start to heat up, eventually
producing sweat in order to cool itself down. The heat produced from the hydrolysis of ATP
travels to the bloodstream which raises overall body temperature, and triggers perspiration 1.
This regulation of the body temperature provides an advantage especially when our bodies
experience a drop in temperature, also known as cold stress. Since we do not have proper
insulation to deal with a cold stress, one of the solutions we employ is through our skeletal
muscles. Shivering is a primary example of this. When we experience cold stress, we shivera process wherein many skeletal muscle groups, begin to contract rapidly at about 20% of
their force-generating capacity 3. This rapid contraction produces a large amount of heat
which travels through the body and increases overall temperature, staving off the detrimental
effects of cold stress.
Recent studies have also pinned skeletal muscle as a possible endocrine organ. An
endocrine organ produces and secretes regulatory hormones into the blood to be transported
all over the body. This is partially seen in skeletal muscle through the secretions of molecules
called myokines 4. These molecules are a type of cytokine, small secreted proteins that have a
targeted effect on the interactions and communication between cells, and have autocrine,
paracrine, and exocrine functions 5. The ability to improve in structure and function while
also combatting the effects of aging and disease seen in skeletal muscle requires a lot of
“cross talk” between different organ systems 4. These organs include the liver, adipose tissue,
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bone, and cardiovascular system (Figure 2) 4. Autocrine and paracrine function of myokines
connect skeletal muscle to organs essential for the regulation of growth and lipid metabolism
of the skeletal muscle, which provides a feedback loop used for adaptation of the muscle to
exercise training 6. Myokines also have an endocrine function that can mediate the wholebody effects of exercise further than that of the skeletal muscle, an example being the
possible counteracting of the pro-inflammatory adipokines released by the adipose tissue
during prolonged inactivity. The endocrine function of the skeletal muscle helps support the
idea that skeletal muscle health is essential for overall health homeostasis of the body.

Figure 2. Stress on the skeletal muscle can induce cell signaling through the
use of myokines Taken from Ost et al., 2016. The myokines produced as a
result of cellular stress are highlighted in red, exercise induced myokines are
highlighted in blue, and myokines produced by both conditions are
highlighted in grey.
4

1.1.3 Attachment of the Muscle Fibers to the ECM
To effect conscious movement, the skeletal muscle contracts, generating a force on the
skeletal system. These local forces can be immense, especially at times of intense exercise,
potentially strong enough to tear the muscle, detaching the fiber from its neighbors or from the
tendon, the band of connective tissue that connects the muscle to bone. To combat this, the
muscle fibers need to be anchored properly to the extracellular matrix (ECM). They are
indirectly anchored to the ECM by transmembrane receptor complexes 7. These complexes are
essential for the proper attachment of the muscle fibers to their ECM which prevents
detachment during contraction. The two receptor complexes (Figure 3) in skeletal muscle fiber
attachment are the integrin-mediated receptor complex and the dystrophin-glycoproteinmediated complex. Each of these complexes consist of a variety of proteins such as dystrophin,
alpha- and beta-dystroglycan, laminin, etc., and are coded for and produced by different genes.
For example, the dystrophin protein (see gray boxes in figure 3) is coded by the DMD gene,
one of the largest genes in the human genome, consisting of about 79 exons and making up
roughly 0.1% of the genome 8. Dystrophin attaches to the actin cytoskeleton, long stiff chains
of actin protein that form part of the cytoskeleton and give the cell structure, with sarcoglycan
proteins on the other end. The sarcoglycans consist of four transmembrane glycoproteins and
respond to muscle contractions, transducing mechanical information into a cellular signal 9.
The next protein structure in the attachment complex is dystroglycan, which consists of two
subunits: alpha- and beta-dystroglycan (purple structures in figure 3). Dystroglycan is then
attached to laminin, one of the most widely expressed ECM proteins (yellow, stick-like
structure in figure 3) 10. It plays critical roles in embryonic development, especially the binding
of the muscle attachment complex to collagen fibers. Collagen is a triple-helix molecule that
5

exists in many different isoforms in many places in the body 11. In the dystrophin-glycoproteinmediated attachment complex, all of these protein structures are connected to one another, and
finally to collagen (gray proteins in Figure 3), where the fiber is secured. Without the
dystrophin protein, the dystrophin-glycoprotein complex (DGC) is disrupted.
These proteins form the complexes that span from the actin cytoskeleton, through the
muscle cell membrane, to the ECM. This structure can be thought of like links in a chain. A
weakening of one of these links can pose a threat to the breakage of the chain, releasing
whatever object is held on at the other end, which is actin in the case of muscle. When one or
more of the proteins do not work properly, or have been weakened, the muscle cell can

Figure 3. Cell Adhesion Complexes are Made Through Many Different Proteins,
Adapted from Goody et al., 2015. Skeletal muscle cell adhesion is done through a
variety of proteins. All of these proteins are coded for in different genes and a
mutation in any one of those genes can cause a form of muscular dystrophy.
detach and undergo cell death. When this happens at a large scale in the muscle, we see
atrophy of the muscle itself. The muscle will then attempt to rebuild broken muscle fiber
cells and will replace it with a greater amount of contractile tissue, a process called
hypertrophy 12.

6

1.1.4 Muscle Fiber Repair and Regeneration
Muscle is one of the most dynamic tissues in the body 2. This is partially due to the
normal protein turnover rate in muscle, aside from that due to damage or stress, which is
about 5.7 g·kg−1·day−1 13. The rate of protein turnover increases greatly during exercise and
the resulting rate depends on the type, length, and intensity of the exercise 14,15. The increased
protein turnover is essential to the repair and regeneration process that occurs in the muscle
fibers after exercise. When a person takes part in intense activity, such as weightlifting, the
person will probably feel a soreness in the muscle groups worked 24-48 hours after the
workout. This soreness is the muscle fibers that were torn and damaged during the workout
being repaired. The muscle fibers will then be repaired, and the contractile tissue will have
increased, improving muscle performance that will decrease damage due to the next intense
exercise. This is called muscle hypertrophy 12.
Regeneration and repair in muscle is coordinated through many different mechanisms
and processes which involve cell-cell and cell-matrix interactions 16. Muscle repair can be
divided into three different phases: the demolition phase, the repair phase, and the
remodeling phase 16,17. The demolition phase is characterized by the sealing of damaged
myofiber ends, inflammation, and the necrosis and clearing of damaged muscle fiber
segments 17. The clearing of necrotic muscle fiber is done through the recruitment of cells
such as macrophages and neutrophils 17,18. The next phase, the repair stage, occurs when
satellite cells activate, proliferate, and differentiate to replace myofiber segments or to form
new muscle fiber cells; formation of fibrous scar tissue occurs in this stage as well depending
on the intensity of the damage 17. The final stage involves muscle fiber repair in order to
restore proper muscle function 17. There typically is a positive gain in the contractile tissue
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which allow for a greater force to be exerted by the muscle during the next session of
exercise 19.
In people with healthy skeletal muscle, this process is repeated whenever the muscle is
damaged, and proper function returns quickly. However, this process can be impaired by
muscle diseases. When this happens, the overall health of the skeletal muscle tissue is
decreased. This leads to a cascade of symptoms all over the body, and an eventual decrease
in quality of life.

1.2 Muscle Disease
There are many diseases and disorders that negatively affect the skeletal muscle. They
can stem from a variety of different origins such as neuronal, congenital, molecular, etc. One
of the most common symptoms of muscle disease is atrophy: the decrease in size of the
muscle fibers, eventually leading to the weakening of the muscle 20. Depending on the
severity of the disease, atrophy of the muscle can impede on everyday activities and often
worsens as the person ages, eventually leading to a decrease in the length and quality of life.
1.2.1 Congenital Muscular Dystrophies
Congenital muscular dystrophies (CMDs) are a group of muscle diseases that occur when
there is a change in the genetic code of the individual in a location essential to skeletal
muscle health and function. These mutations in the DNA cause a loss of function in the
proteins that anchor the muscle fiber to the basement membrane. When there is improper
anchoring, the muscle fiber can detach and undergo cell death.
Symptoms of CMD is often initially observed in infants (although late onset is possible).
Abnormal motor movements, such as trouble walking or use of their limbs, are initially seen
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in young patients, followed by a progressive weakness which may lead to the loss of the
ability to walk or use of limbs. However, different CMDs affect different muscle groups at a
differing severity level. Some CMDs may affect the cranio-facial or ocular muscles while
others effect the muscles at the limbs and shoulders. The most common CMDs are Duchenne
and Becker muscular dystrophies (DMD and BMD, respectively), which effect
approximately 1 in every 5,500 to 7,700 men age 5 to 24 21. In the case of this study, DMD
will be the primary focus. However, any mutations in the DNA that code for the proteins in
the adhesion complexes can cause a different CMD. Examples of these are ITGA7 (integrinalpha 7), LAMA2 (laminin-alpha 2), and COL6-RD (collagen VI) genes.
Mutations in ITGA7 cause a congenital myopathy due to a loss of function in the integrin
proteins in the adhesion complex (figure 3). Mutations in the laminin-alpha 2 proteins coded
for in the LAMA2 gene cause LAMA2 CMD also known as merosin-deficient congenital
muscular dystrophy (MDC1A) and is characterized as early onset and very severe 22.
1.2.3 Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy (DMD) is a congenital muscular disease caused by a Xlinked mutation in the Dystrophin. This causes a loss of function in the dystrophin protein. It
is usually diagnosed at an average of about 4 years of age, with symptoms often progressing
quickly 23. Increased muscle weakness, loss of the ability to walk at a young age, respiratory
and cardiac issues, and a lower quality of life are among the most common symptoms, with
disease progression ultimately ending in a shortened life span.
The dystrophin gene is a very large gene, spanning about 0.1% of the genome with more
than 2,200 kb 8. Surprisingly, despite its size, the dystrophin gene only contains about 79 exons,
making up only a small percentage of the gene (about 0.6%) 24. Mutations that cause DMD
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mostly stem from deletions of one or more exons 23. This makes up about 65% of the cases,
while duplications make up about 6%-10% of the case, and the rest consisting of small
mutations (missense, nonsense, and splice site variations)

23

. These mutations interrupt the

open reading frame (ORF) and lead to the absence of dystrophin protein throughout the body.
A shift in the ORF that does not cause a complete absence of the dystrophin protein, but a
partially functioning, abnormal shaped protein, you get Becker muscular dystrophy (BMD), a
more mild form of DMD 25. Without the dystrophin protein, there is detrimental effects of the
muscle across a large majority of the muscle. It even extends past the skeletal muscle, as
patients often show an abnormal electrocardiogram by the age of 18, indicating symptoms
within the cardiac muscle and respiratory system and leading to an early death in their late
teens to early twenties

26

. Disease progression in DMD and other muscle disease stress the

importance of skeletal muscle health and how it is linked to overall health of the body and the
need for further therapies and an eventual cure.
1.2.4 DMD Patients Have Lower Activity Levels
Movement abnormalities and difficulties are common symptoms of DMD with a loss of
movement independence and the need for a wheelchair occurring by around the age of 10 23.
Activity levels are severely reduced by this time in severe DMD patients. Without proper
dystrophin function, muscle fibers are be more susceptible to damage and the regenerative
abilities of myofibrils is hindered 23. Strenuous exercise or activities that a healthy person would
normally partake in such as a run or bike ride is highly advised against, as irreversible damage to
the muscle fibers could ensue and exacerbate disease progression 27. Despite the potential
damage to muscle and muscle fibers, it is debated that exercise in muscle disease patients may
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provide a potential therapeutic effect, since exercise in a healthy person has many benefits on
overall health and wellness.

1.3 Exercise and Inactivity on Muscle Structure and Function
It is accepted widely that a normal exercise routine is imperative for the function of the
human body. Numerous studies have shown that normal exercise reduces the risk for many
different diseases such as coronary heart disease, hypertension, diabetes mellitus, and can
extend the life expectancy of a person

28

. Alternatively, insufficient activity and sedentary

lifestyles have the opposite effects. Gain of abdominal and visceral fat and a higher risk of type
2 diabetes and heart disease are among many other symptoms that may arise from the lack of
regular exercise 29. Done under proper conditions, exercise is among one of the most important
things that can be done to improve health and quality of life in a healthy individual.

1.3.1 Exercise and Its Beneficial Effects on the Body
Regular exercise, especially dynamic exercise of moderate intensity, improves endothelial
function, vascular tone regulation (through the increase of endothelial nitric oxide production)
that staves off cardiac-related illness, and improves movement abilities 30. In younger people,
exercise shows similar benefits such as a lower heart rate, left ventricular ejection fraction,
maximal oxygen uptake, and lower risk of diseases such as type 2 diabetes and heart disease
31

.
When a person goes through intense exercise, they are putting strain on their muscle fibers

and whether they know it or not, they are putting these fibers through a cycle of breakdown
and regeneration. As explained in section 1.4, when undergoing damaging force, such as an
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intense power-lifting workout, many muscle fibers break, the damaged tissue is then broken
down, and contractile tissue is regenerated, often with additional tissue. The addition of new
contractile tissue lets the muscle exert that same force with less damage to the muscle fibers.
The consistent addition of contractile tissue due to intense exercise is called muscle
hypertrophy. Athletes and power-lifters utilize hypertrophy to build muscle strength and
improve performance.

1.3.2 Inactivity and Its Detrimental Effects on the Body
Regular activity clearly shows various benefits to the overall health of the body.
Conversely, prolonged inactivity has been shown to have a variety of negative effects on the
health and function of the body. Not meeting the minimum recommended amount of activity,
which is about 30 minutes of moderate-intense physical activity 5 days a week, is a problem
seen across all life stages from childhood past adulthood

29

. Prolonged inactivity not only

decreases muscle mass and strength, but it is shown to be positively associated with all-cause
mortality, fatal and non-fatal cardiovascular disease, type 2 diabetes, and metabolic syndrome
32

.
Inactivity has a profound effect on the skeletal muscle of an individual. Increased

fatiguability upon resumption of activity, loss of muscle mass, and mitochondrial dysfunction
are all linked to prolonged inactivity 33–35. When a person becomes inactive, over time there
is a reduction in protein synthesis and an increase in proteolysis due to the decreased use of
transcriptional activity 35. The person is no longer using their muscle fibers beyond that of
basic movement, which basically tells the body there is no use for excess proteins or
transcripts of those proteins. When this happens, the body starts to breakdown those proteins
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and their transcripts, ultimately diminishing the amount of muscle fibers. This is a process
called muscle atrophy. With muscle atrophy, there is also a weakness of the muscles and a
decreased amount of force those muscles are able to generate. About 1 week of inactivity,
such as bed rest decreases as much muscle as would be gained from 12 weeks of intense
resistant-type exercise training 36.
Muscle disease patients, including DMD patients, experience high levels of muscle
atrophy, reducing functionality of those muscles, and lowering activity levels. Gradual
resumption of activity in a healthy individual can rebuild muscle groups, reduce adipose
tissue deposits, and reduce the risk for illness. However, in an individual with an illness such
as muscle disease, the process of activity versus inactivity becomes more complicated.

1.3.4 Exercise and Activity and Its Effect on Muscle Disease
The main hallmark of muscle disease is increased muscle atrophy. The breakdown of
muscle fibers and weakening of the muscle groups is due largely to the damage sustained to
the fibers from improper anchoring to the ECM. With a lack of proper anchoring, the rate of
breakdown exceeds that of the rate of regeneration, and damage to the muscle ensues. As
there is no current cure for muscle disease, there is a large stress put on therapies in order to
extend quality and length of life. Physical therapy is typically the most used therapy to help
combat DMD and may include some type of exercise. While a current set of international
care guidelines exists and recommends individuals engage in regular submaximal activities,
large-scale randomized control trials are lacking, and data between smaller studies is variable
27,37–40

. For example, a study done by Voet et al. published in 2019 had participants with

certain muscle diseases (DMD among them) take part in strength training, aerobic exercise,
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or a combination of both in order to assess the benefits or harm to muscle strength and
aerobic capacity 41. The researchers showed uncertainty in their results and failed to show
concrete evidence of improvement to muscle strength or aerobic capacity 41. Due to
limitations in human studies and variability in data, researchers have turned to animal models
in order to explore and understand mechanisms behind DMD and other muscle diseases.
1.3.5 Animal Models of DMD and Exercise
Currently, there are about 60 different animal models of DMD ranging from mammalian
such as canine, feline, and mouse models, to non-mammalian models including C. elegans,
fruit fly, and zebrafish models 42. The most widely used animal model of DMD is the mdx
mouse, Mus musculus, discovered in the 1980s 42. The mutation in the mdx mouse is a
nonsense point mutation, C-T transition in exon 23 that aborts the full-length dystrophin
expression 42,43. Studies with exercise and mdx mouse have shown inconsistent results, but
recent studies show more promising results. For example, a study done by Zelikovich et al.
published in 2019 tested the effects of moderate and low intensity exercise on tetanic and
specific force, respiratory capacity, and cardiac function 44. They found that exercised mice
mdx mice improved tetanic and specific force, increased respiratory capacity, and enhanced
cardiac function as compared to the sedentary group. The researchers also found a dosedependent increased in serum adiponectin, a protein hormone responsible to the influence of
the body’s response to insulin.
While many exercise studies of DMD have been performed, studies on inactivity and its
effects on disease mechanisms and progression are lacking. It is well established that
individuals suffering from DMD exhibit lower activity level compared to healthy individuals
from even a very young age 45. Two studies of inactivity in mdx mice show that prevention of
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exercise preserves muscle fibers integrity and prevents myonecrosis 46,47. Another study done
by Li and Arner in 2015 chemically induced inactivity with BTS in dmd mutant zebrafish
from 18 hours post fertilization (hpf) to 4 dpf which resulted in better organization of muscle
fibers seen from birefringence compared to the active controls, further suggesting that
inactivity helps preserve muscle fibers 48.
Conversely, a study done by Hourdé, C. et al in 2013 found that inactivity in mdx mice
may lead to an increase in susceptibility to contraction-induced injury and that voluntary
activity may help protect from this susceptibility 49. Another study done on mdx mice by
Lindsay et al. in 2021 that had a stress-induced short period of inactivity showed that
inactivity was not associated with acute skeletal muscle contractile dysfunction, but high
passive stiffness could be possibly attributed to a small, but significant increase in muscle
fibrosis 50. Since these findings are varied, more research is needed in order to fully
understand the effects inactivity is having on DMD.
While mdx mice are a widely used model and allow us to research deeper into the
mechanisms behind DMD without the limitations of human models, there are limitations to
mice models as well. Young mdx mice show little weakness and live up to 80% as long as
their healthy control counterparts, far longer than human DMD patients 42. It has been
hypothesized that this may be attributed to an upregulation of utrophin seen in mdx mice not
seen in humans. Efforts to “humanize” the mdx model show variable results, and more
research is needed in order to establish a more “human model” of mouse DMD 51. However,
other animal models are being increasingly used to study DMD, even in exercise studies. One
example is zebrafish (Danio rerio). A study done by Kilroy et al. published in 2020
compared inactivity and neuromuscular electrical stimulation (NMES), the zebrafish version
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of exercise, on a zebrafish model of DMD 45. They found that NMES returns gene expression
to wild-type levels, increases muscle adhesion to the ECM, and remodels the ECM to support
more regeneration, while inactivity had a deleterious effect on disease progression. These
results provide further evidence that exercise is beneficial for DMD patients and inactivity
may have a negative effect on disease progression. The use of zebrafish has been
increasingly used for a variety of studies and provides an attractive model to study DMD.

1.4 Zebrafish as a Model of Study
Zebrafish (Danio Rerio) have been widely accepted as a useful model for developmental
biology and genetics experiments. Zebrafish development is rapid, as embryos fully develop
their major organ systems, including cardiovascular, nervous, digestive, and muscle systems,
in less than a week 52. While they develop, the skin is transparent which makes observation
and imaging of organ system development especially easy and efficient. There is also high
fecundity in zebrafish; females are able to produce many offspring, potentially up to 350
offspring in a week 53. To reproduce, zebrafish fertilization is external, which lets the
embryos be collected shortly after fertilization occurs, providing researchers access to all
stages of development. The high fecundity and rapid development allow for multiple
experimental trials be conducted over a relatively short amount of time.
The cost of maintenance of zebrafish is relatively low as well. The embryos do not need
food until 5 days post fertilization, which is the conclusion of many developmental
experiments as their organs have already developed. Different transgenic or mutant lines are
also able to be purchased for relatively low cost and kept for over 2 years. The small size of
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the adult zebrafish also allows for multiple fish to be kept in the same tank, reducing the need
for multiple tanks at large sizes, keeping maintenance costs low.
Zebrafish are also used as a model of study due to the molecular tools available and their
genetic amenability. Examination of specific gene function through the development of
transgenic lines, large scale mutagenesis screens, or antisense gene knockdown is highly
achievable with zebrafish 52. It has been shown by the UK Sanger institute that almost 70%
of human genes have functional homologs in zebrafish, including many of the genes that
code for the proteins that attach the muscle fiber to the basement membrane 54. Genetic and
functional conservation is important because that means that zebrafish display similar
phenotypes resulting from the same mutations in their genome as humans. In other words, a
mutation in a gene that encodes for a protein involved in muscle attachment in a zebrafish
will produce similar muscle attachment deficiencies as mutations in the homologous human
genes.
Two common methods of investigating gene function in the zebrafish model are
morpholino-mediated protein knock down and CRISPR/cas9 mutagenesis. Morpholino (MO)
antisense oligomers are synthetic oligonucleotides that interfere with mRNA translation or
processing, which results in protein knock down or a “pseudo” mutant scenario. Advantages
to MOs are that large numbers of “pseudo” mutants can be generated for experiments and
maternal and embryonic proteins are both knocked down. Disadvantages include only
temporary protein knock down, injection variability, off-target effects, and results that often
don’t line up with mutant findings 55. Alternatively, we can now relatively easily alter DNA
sequences through CRISPR/cas9 mutagenesis. This system allows genome editing of
different species using specific RNA segments and the Cas9 enzyme to cut the target DNA
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sequence and replace it with a customized DNA sequence 54. Research labs and institutes are
using this technique to create mutant lines of zebrafish to model different genetic diseases.
1.4.1 Zebrafish Muscle Development
Zebrafish muscle development makes them an ideal model to study muscle disease. The
development and physiology of skeletal muscle in zebrafish shares many commonalities with
higher vertebrates, including mammals such as mouse and dog models 56. However, there are
differences in the skeletal muscle of zebrafish compared to higher vertebrates that can be
viewed as experimental advantages. In zebrafish, the different muscle fiber types, fast-twitch
vs slow-twitch, are spatially segregated. This allows for the observation of fiber-type specific
effects when experimenting while also providing an opportunity for identifying the
mechanisms that regulate fiber-type specification 56. Development of the muscle is also
easily observed. Skeletal muscle development in zebrafish is rapid and completed in a few
days. The muscle originates from somitic cells as the precursors to the individual fibers.
These precursor cells elongate and eventually become the actual muscle fibers, which are
then separated into segments called myotomes (figure 5) 57. These myotomes are
characterized by having a sideways “V” shape, also known as a chevron, with an angle of
approximately 90º. The myotendinous junction (MTJ) separates the myotomes and is the area
in which attachment to the ECM occurs. Proper MTJ anchoring is essential for fiber health
and overall muscle health.

1.4.2 Zebrafish Model of DMD
For this project, we used dmd zebrafish to model human DMD 58. dmd mutant zebrafish
result from a nonsense mutation that leads to a premature stop codon in the zebrafish
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orthologue of the human Dystrophin gene and result in dystrophic pathology by interrupting
the link between the actin cytoskeleton and the ECM in skeletal muscle cells 58,59. The
disease progression of dmd mutant zebrafish mimics that of a human patient very similarly as
opposed to the mdx mouse model. Similarity to the human disease, combined with the
advantages of a zebrafish model outlined in section 4 allow for a useful and potentially more
relevant model of DMD. Birefringence imaging (Figure 6E) allows for easy visualization and
quantification of disease progression, while tools such as DanioVision and
immunohistochemistry (IHC) allow for further analysis into muscle function and structure,
respectively. Overall, dmd mutant zebrafish provide an excellent model of DMD and are the
model used to conduct this project.

Figure 4. The Development of Skeletal Muscle from Somites: Adapted from Goody, Carter, Kilroy,
Maves, & Henry, 2017. The development of skeletal muscle starts with the somite (pictured on
the right) which contains short-precursor cells. These cells elongate, attach to ECM, and then
form the multinucleated striated skeletal muscle fibers within the myotome (pictured to the
left).
1.5 Project Overview
The sole study examining the effects of inactivity on dmd mutant zebrafish showed a
deleterious effect on muscle structure and function 45. This project aims to expand the
research done on inactivity in DMD mutant zebrafish, to further understand the underlying
mechanisms of disease progression and effects on muscle structure and function. We
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hypothesize that extended inactivity will have a negative effect on the structure and function
of the muscle along with a lower probability of survival in dmd mutant zebrafish.
Inactivity was induced through a N-benzyl-p-toluene sulphonamide (BTS) solution, an
inhibitor of the Ca2+-stimulated S1 ATPase that blocks gliding motility 60. BTS has been
shown to prevent any force transduction or movement in zebrafish, with little effect on the
M- and Z-lines of the muscle fibers 61. Zebrafish mutants and wild-type (WT) controls were
either treated with 50 µM BTS solution, inducing inactivity, or put in a DMSO control
treatment at the same concentration. Birefringence imaging was done to quantify disease
severity and progression through calculation of mean grey value (MGV), DanioVision was
used to analyze muscle function through measurements of distance (in mm) and velocity (in
mm/s). The results of this study help to further understand the mechanisms behind inactivity
and DMD in hopes to apply the data into a broader context to properly address treatments
and therapies for patients diagnosed with DMD.
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CHAPTER 2:
MATERIALS AND METHODS
2.1 Materials
2.1.1 1x ERM
To prepare a 20X stock solution the following was added to 800 mL of ddH2O: 17.5 g
NaCl, 0.75 g KCl, 2.9 g CaCl-2H2O, 0.41 g KH2PO4, 0.142 g Na2HPO4 anhydrous, and 4.9 g
MgSO4-7H2O. Once in solution, ddH2O was used to fill up to 1 L. This solution was then filter
sterilized into an autoclaved 1-L flask and stored at +4 ºC. 1X ERM was prepared by adding 50
mL of the 20X stock solution, 0.3 g of NaHCO3, and one to two drops of methylene blue to 950
mL of autoclaved ddH2O. 1X ERM was stored at room temperature.
2.1.2 Tricaine
Tricaine was used to briefly halt movement in order to properly image birefringence. A
stock solution of tricaine (MS-222, Sigma-Aldrich) was prepared by adding 400 mg of powered
tricaine and 800 mg of Na2HP04 (Anhydrous) to 100 mL ddH20. The pH was adjusted to 7.0 if
necessary, with 1M HCl or 1M NaOH. The stock solution was aliquoted and stored at -20 ºC.
Working solutions were prepared daily for live imaging by adding 400 μL of the stock solution
to 10 mL of 1X ERM (612 μM)
2.1.3 BTS
N-benzyl-p-toluene sulphonamide (BTS) was purchased from Sigma-Aldrich in a 5 mg
powder. The BTS powder was dissolved in 382.64 µL DMSO to make the stock solution and
was kept at -20 ºC. To achieve a 50 µM as outlined in Codina et al., 3µL of the BTS stock
solution was placed in 3 mL of ERM for each well-dish 61.
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2.2 Methods
2.2.1 Zebrafish Care and Maintenance
Adult zebrafish were kept on a 28.5ºC 14-h light/10-h dark cycle and embryos were
collected from natural spawning of these zebrafish. We used sapjeta222a zebrafish for all
experiments 58. Embryos were staged based on Kimmel et al., 1995 62. Experiments were
conducted with the approval of the University of Maine Institutional Animal Care and Use
Committee (IACUC). Embryo Rearing Media (ERM) was made in a 1 L bottle with 0.3 g
NaHCO3, 50 mL 20x ERM stock, and brought to 1 L with ddH2O. Two drops of methylene blue
were added after the ddH2O. Embryos were housed individually at 2dpf in 4x3 12 well-plate
dishes with 3 mL embryo rearing medium (ERM) during experiments. Once at 5 (dpf), zebrafish
were fed once daily. At 9 dpf, ERM was switched out with system water that the adult zebrafish
are housed in.
2.2.3 Birefringence Analysis
Birefringence is a unique and physical property in which light is rotated as it is passes
through highly organized matter, such as the pseudo-crystalline array of muscle sarcomeres 63.
With zebrafish larvae being optically transparent, birefringence is a rudimentary and efficient
way to quantify dystrophic muscle and ultimately, disease progression, as damaged muscle does
not reflect light. Zebrafish were placed in 612 μM of tricaine in 1X ERM immediately
prior to imaging and then transferred to a 35-mm glass bottom dish. Birefringence images were
taken on a Leica MZ10 F Stereomicroscope with a Zeiss AxioCam MRm or Leica DMC5400189
camera attached. An analyzer in a rotatable mount (Leica) was attached to the objective and the
glass-bottom petri dish was placed on the polarized glass stage.
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Zebrafish displaying well organized myotomes with bright white or light grey muscle
were classified as wild-type (WT) siblings while those that had patchy dark grey or black areas,
indicating dystrophic or disorganized muscle fibers, were classified as dmd mutants. Imaging
parameters and time was consistent across experiments.
Images were blinded before analysis and mean grey values (MGV) were calculated using
FIJI software 64. The body of the zebrafish was outlined from the 7th to the 23rd myotome using
the “polygon selections” tool and then MGV was measured. This was done three times to obtain
three separate measurements, and then the average was used for calculations. All birefringence
data were normalized to the average WT birefringence in each imaging session. MGVs were
then presented as a percentage of the average MGV. The equation is below:

𝐸𝑚𝑏𝑟𝑦𝑜′ 𝑠 𝑀𝐺𝑉
𝑥 100
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑀𝐺𝑉 𝑜𝑓 𝑠𝑖𝑏𝑙𝑖𝑛𝑔 𝑐𝑜𝑛𝑡𝑟𝑜𝑙

Birefringence was used to assess the change in muscle structure and quantify disease
progression from 2 dpf to 8 dpf. A positive change in birefringence corresponds to an
improvement in muscle structure. Conversely, a negative change in muscle structure meant there
was a worsening of muscle structure.
2.2.3 DanioVision Analysis
The DanioVision system and EthoVision XT 13.0 software (Noldus Information, Inc)
was used to conduct high-throughput locomotion tracking studies to observe and quantify muscle
function during inactivity at 5 dpf and 8 dpf. DanioVision uses a high-speed, infrared-sensitive
camera to track movement of zebrafish. During the experiments, zebrafish were kept in their 12well plate wells and placed into the DanioVision observation chamber. The temperature was kept
23

at 28 ºC and a temperature control unit was used to ensure the temperature stayed constant.
Zebrafish were allowed to acclimate to the temperature for 5 minutes. Using the EthoVision
software, the zebrafish went into a period of dark followed by two light-on/off cycles, where the
white light was turned on at 100% intensity for 5 minutes and then turned off for 5 minutes 45.
Total recording time was 25 minutes.
Once recording was finished, the data was exported into an Excel file. Raw data includes
distance swam in mm and mean velocity across 0.033-second periods. Distance and velocity
were analyzed in GraphPad Prism 9.
2.2.4 BTS Inactivity Experiment
Zebrafish embryos were collected and grown until 2 dpf, the day of disease onset. At 2
dpf, birefringence images were taken as described in section 2.2.3. The embryos were then put
into individual well dishes in a 12-well plate, separated by treatment group. There were 4
treatment groups: WT Inactive, WT, dmd Mutant Inactive, and dmd mutant. The BTS-induce
inactive groups received 3 µL BTS stock solution in 3 mL ERM. The CT groups were treated
with 3 µL DMSO. From 2 dpf to 5 dpf, the ERM solutions were changed daily at approximately
the same time. At 5 dpf, the zebrafish were removed from the treatment groups and birefringence
images were taken. The zebrafish then were placed into 3 mL ERM with no treatment solution.
DanioVision was done 4 hours later to allow proper time for activity to resume. ERM was
changed daily at approximately the same time until 8 dpf. At 8 dpf, birefringence images were
taken and DanioVision was done 4 hours later. The embryos were then tracked for survival and
deaths were recorded as days post fertilization.
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2.2.5 Statistical Analysis
All statistical analysis was done in GraphPad Prism 9. Normality of the data was first
tested using the Shapiro-Wilk test. If the data set passed the normality test, an unpaired twotailed t test was performed between two data sets (i.e., dmd inactive mutants versus dmd mutant
controls). An ordinary one-way ANOVA followed by a Turkey’s multiple comparison test was
performed between the four treatment groups’ data sets. If the data set failed to pass the
normality test, a Mann-Whitney U test was performed to compare two data sets while a KruskalWallis test was performed to compare the four treatment groups’ data sets. Significance for all
tests was set to p < 0.05.

CHAPTER 3:
RESULTS
3.1 Transient BTS Treatment Does Not Alter Muscle Structure in dmd Mutant Zebrafish
We sought to analyze the change in muscle structure in dmd mutants as compared to the
control treatment groups through calculation of percent MGV in order to quantify the dystrophic
muscle. We found that at 2 dpf, 5 dpf, and 8 dpf, there was no significant difference between the
dmd mutant inactive and dmd mutant groups (Figure 6A, B, C,). Also, there was no significant
different between the WT and WT inactive groups at 2 dpf and 8 dpf (Figure 6A, and C).
Over the three time periods, we saw a decrease in MGV from 2 dpf to 5 dpf in the WT
Inactive, dmd mutant inactive, and dmd mutant groups, followed by an increase in MGV in the
WT Inactive group only (Figure D). The dmd mutant and dmd mutant inactive groups followed a
similar trend throughout all time groups (Figure D). WT MGV did not change over the time
periods (Figure 6 D). These findings provide evidence that the dmd mutant inactive zebrafish
25

followed the same disease progression as the active dmd mutant zebrafish over time, suggesting
that inactivity is neither hindering nor improving muscle structure in this mutant. Also, these data
shows us that inactivity has a detrimental effect on WT muscle that can be recovered shortly
upon resumption of activity.
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Figure 5. Inactivity does not have a negative effect on muscle structure. (A.) Percent MGV at
2 dpf shows no significant different difference in percent MGV between the dmd Mutant and
dmd Mutant Inactive groups as well as the WT and WT Inactive groups. (B., C.) Percent
MGV at 5 dpf as well as 8 dpf shows no significant difference between the dmd Mutant and

3.2 Muscle Function in dmd Mutant Zebrafish is not Affected By BTS-Induced Inactivity.
We next sought to understand the effects of inactivity on muscle structure in the dmd
inactive mutants as compared to the CT treatment groups. We used DanioVision to measure
distance (in mm) and velocity (in mm/s) in order to quantify swimming ability and attribute that
to muscle function. We saw no significant difference in distance or velocity between the dmd
mutant inactive and dmd mutant groups as well as the WT inactive and dmd mutant groups at 5
dpf (Figure 7A, B). At 8 dpf, the only significant difference in distance was between the WT
inactive and the dmd mutant inactive groups (Figure 7C), while with velocity, the only
significant difference was between the dmd mutant groups and the WT groups (Figure 7D).
These findings show that muscle function analyzed through distance and velocity was not
different between the dmd mutant and dmd inactive mutants at either 5 dpf or 8 dpf, suggesting
that inactivity does not have a detrimental effect nor an improvement in muscle function.
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Figure 6. Inactivity does not have a negative effect on muscle
function via distance and velocity. DMSO sapjes were not
significantly different in distance or velocity from BTS sapjes at 5
dpf (A and B). At 8 dpf, the only groups that were significantly
different was the BTS sapjes and the WT BTS group for distance (C)
and the BTS sapje and the WT DMSO for velocity (D).
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CHAPTER 4:
DISCUSSION
After analysis of the percent MGV throughout the time periods, we did not see a
significant difference between the dmd mutant group and the dmd mutant inactive group (Figure
6A-C). This shows that while inactivity is not making dmd inactive mutants worse than the
control mutants, it is not helping the dmd inactive mutants improve in muscle structure. Often
times, a patient suffering from DMD becomes inactive or is told to reduce activity to simply
going about their daily life, in order to preserve the muscle fibers. Our data did not provide any
evidence that inactivity preserves muscle fibers and disease progression follows a similar pattern
to the control mutant group. Conversely, previous data by Kilroy et al. show a worsening effect
on muscle structure after the same period of inactivity when compared to the control mutant
group 45. The difference in our data could be attributed to the chemical used to induce inactivity.
Kilroy et al. used tricaine (MS-222) for their inactivity studies. Tricaine works by blocking the
voltage-sensitive sodium channels, preventing a voltage-dependent increase in sodium
conductance, and ultimately blocking muscle contraction 65. Adverse effects are seen mostly in
the CNS and cardiovascular system; however, it is not yet fully understood. A common response
to zebrafish treatment with tricaine is elevation of heart rate and respiration, followed by a
depression of cardiovascular and respiratory function, resulting in hypoxia, a lowered
concentration of blood O2

65

. While not a direct effect on the musculature, lowered blood

concentration and changes in heart rate could have residual effects on already damaged muscle
due to dmd that are not seen in BTS treatment in zebrafish.
Another study similar to what was done in this thesis is by Li and Arner et al. in 2015.
The researchers here used 50 µM of BTS to induce inactivity in dmd mutant zebrafish at 18 hpf
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and was done through 4 dpf. They found that the BTS treated dmd mutants displayed higher
birefringence when compared to the DMSO control dmd mutants and was confirmed through
quantification of birefringence intensity 48. These data contradict what was found in this thesis,
as we did not see an improvement in the muscle structure when compared to dmd mutant
controls. One of the reasons for this could possibly be attributed to time of treatment. Whereas
our dmd mutants entered BTS-induced inactivity at 2 dpf, the BTS-induced inactivity treatment
in Li and Arner’s experiments began at 18 hpf. At this time, zebrafish are not free swimming, as
muscle development and organization is still occurring 57. At 2 dpf, the muscle has been
developed and the larvae are free swimming, opening up an increased opportunity for
contractile-induced damage, especially in dmd mutant zebrafish, that would otherwise not occur
with inactivity beginning at 18 hpf. This would preserve muscle fiber integrity starting at 18 hpf
and since the researchers did not look at muscle birefringence after resumption of activity past
one day post BTS washout, it is likely that there would be no evidence of dystrophic muscle
within the time of treatment. It is important to wait until disease onset to initiate the treatment
groups because DMD patients often first get diagnosed after there is already damage due to
normal activity levels (typically in children). The dmd mutant zebrafish in the research presented
in this thesis started out with dystrophic muscle due to their swimming levels being higher prior
to BTS treatment and data was also collected 3 days post-BTS washout, which could account for
the difference in results.
We also saw that WT inactive muscle structure was significantly decreased from 2 dpf to
5 dpf. This negative effect of inactivity was what we expected to happen, however, it was not a
lingering effect, as structure improved to WT levels after 3 days of activity resumption. This
shows us that the experimental conditions were working, and inactivity negatively effects muscle
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structure. Unfortunately, we did not see this negative effect with the dmd mutant inactive group
when compared to the dmd mutant. This could possibly be attributed to the fact that the dmd
mutant inactive embryos were already suffering from their muscle weakness initiated by dmd.
Since the WT inactive embryos were at similar levels to dmd mutants after their treatment, dmd
mutants possibly already were suffering from the impacts of dmd that manifested worse than the
effects of inactivity.
In BTS treatments, there have been reports of disruption of the thick and thin filament
organization in zebrafish, as BTS works through inhibiting myosin function through the
blockage of ATPase activity and interaction with α-actin 61. This disruption in the interaction
with α-actin causes disruption with the organization of the thick and thin filaments, with little
effect on the M- and Z-lines 61. This disorganization may account for lower percent MGV
measurements in BTS treatment groups, as birefringence imaging relies on highly organized
structures, such as the sarcomere, to reflect light and glow under the polarized lenses. While this
is something to consider, we saw that the dmd mutant inactive group had similar percent MGV
measurements as the dmd mutant group and were not significantly different at any of the three
time periods. Therefore, it is unlikely there was a significant effect on the disorganization of the
thick and thin filaments that could be seen with birefringence. While it would be difficult to
observe the organization of the thick and thin filaments at the current time,
immunohistochemistry staining with phalloidin would fluorescently label the actin and would be
a first step in seeing how BTS may be affecting the thick and thin filament organization.
There was also no significant difference in the muscle function, via swimming distance
and velocity, between the dmd inactive mutants and the dmd mutants at 5dpf. This shows that
immediately after a period of inactivity, swimming ability was no different than the control
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mutants who were not inactive. The lack of a significant difference could be attributed to the
differences in mild versus severe phenotype of the disease. DMD can have a varying severity and
the embryos were not separated based on mild versus severe phenotypes. It is possible that one
group may have had more severe mutants than another, and vice versa. This may have shown an
evening-out effect of the distance and velocity between the BTS mutant group and the DMSO
mutant group. Percent MGV calculations can be used to separate groups and observe differences
in mild versus severe phenotypes. This can be done to see if the difference in phenotype could be
affecting the swimming distance and velocity.
Also, the lack of significant difference between the WT inactive group and the dmd
mutant group at 5 dpf in both distance and velocity could be attributed to the decrease in muscle
mass resulting from inactivity. In a healthy individual, a period of inactivity reduces muscle mass
and strength. Since the muscle is no longer being used, the proteins are broken down and the
amount of contractile tissue is reduced. This can be seen in the WT inactive group. Since they
are inactive, the muscle function is reduced to the levels similar to diseased, dystrophic muscle.
Resumption of activity increases muscle function back to WT levels. This data helps to support
our model of inactivity.
At 8 dpf, there is no significant difference between any group other than the BTS sapje
and WT inactive groups with distance and WT and dmd mutant groups with velocity (Figure
7C). This could be due to improvement in swimming abilities in the inactive groups. There may
be an increase in distance and velocity from 5 to 8 dpf in the inactive groups that could account
for the lack of significant difference between the groups, since there was 3 days allowed to
recover and train the body to move about. However, it is difficult to accurately compare the
changes in distance and velocity from 5 dpf to 8 dpf due to one replicate at 8 dpf not being
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conducted because of having to quickly quarantine due to a COVID-19 scare along with another
replicate’s data at 8 dpf not being saved properly on the DanioVision computer. All other
experiments were conducted without problems. Further study into the change in distance and
velocity may help shed light on the lack of significant differences between the groups.
Regardless, there is still no significant difference between the dmd mutant group and the dmd
mutant inactive group, showing that inactivity was not making muscle function worse than the
mutant controls.
This study can be improved in multiple ways. One of the ways that would improve the
study the most would be separation of mild versus severe phenotypes. Mild versus severe can be
calculated from percent MGV and embryos can be divided more evenly amongst the groups.
This would potentially reduce the variation in muscle function and structure, along with survival
that could possibly have skewed our results and provide a clearer picture of what may be
happening as a result of inactivity. Also, human DMD shows variability in the severity as well,
so separation of the mild and severe zebrafish would allow for a better parallel to the human
disease.
In combination with separation of mild versus severe, another way of improving the
study would be to collect MGV data over each day, as opposed to the three time points. This
would allow us to see the change in muscle structure over time more clearly. Kilroy et al. 2020
saw a difference in the change over time in percent MGV between mild and severe at 5 dpf to 8
dpf 45. She saw that the mild inactive dmd mutants, while having higher percent MGV,
experienced a more dramatic decline in their percent MGV after entering the recovery period at 5
dpf. The severe inactive dmd mutants, having lower percent MGV, had a less dramatic decrease,
but ended up reaching the same MGV levels at 8 dpf as the mild inactive dmd mutants. It would

33

definitely improve this study to see if there was the same pattern in the inactive dmd mutants in
this project as well. Also, using DanioVision of the DMSO groups each day starting at 2 dpf and
DanioVision of the BTS groups each day starting at 5 dpf (since there would be no movement in
the BTS treatment from 2 dpf to 5 dpf) to analyze changes in muscle function over time could
show how muscle function changes day by day. Collecting data over more timepoints overall
would provide more information on how the disease progression is changing over time.
Immunohistochemistry staining of the muscle actin as well as the neuromuscular
junctions (NMJ) would allow for a more in-depth look at the muscle physiology. Since Kilroy et
al. induced inactivity through the neurons, it would be helpful to observe any differences in the
NMJs between tricaine-treated and BTS-treated zebrafish. This could potentially explain
differences in the data from the two studies. Furthermore, staining actin and myosin molecules
would allow us to see if there was any disorganization of the thick and thin filaments as was
previously shown to be attributed to BTS treatments. This would negate any potential decrease in
percent MGV due to disorganization of these filaments and not the muscle disease phenotype
itself.
From the data we collected, we can conclude that BTS-induced inactivity does not have a
negative effect on the disease progression in DMD mutant zebrafish. Muscle function and
structure, along with survival, was not significantly different in the BTS mutant zebrafish as
compared to the DMSO mutant zebrafish. The inactive mutants seemed to follow a similar
disease progression as the control mutants. In a broader context, this provides evidence that
inactivity to preserve muscle fiber integrity in DMD patients may not be helping stave off the
effects of DMD. It is imperative that more research be done with inactivity and muscle disease

34

so that proper treatments and therapies can be applied to those diagnosed with any form of
muscle disease to extend and improve the length and quality of life.
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